SH2 Domain Containing 1A (SH2D1A) Peptid
SH2D1A
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle SH2D1A Produkte
- SH2D1A (SH2 Domain Containing 1A (SH2D1A))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- YFRKIKNLIS AFQKPDQGIV IPLQYPVEKK SSARSTQGTT GIREDPDVCL
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SH2 D2 antibody,
Alternative Names: SH2D1A control peptide, SH2D1A antibody Blocking Peptide, Anti-SH2D1A Blocking Peptide, SH2 domain protein 1A Blocking Peptide, DSHP Blocking Peptide, EBVS Blocking Peptide, FLJ18687 Blocking Peptide, FLJ92177 Blocking Peptide, IMD5 Blocking Peptide, LYP Blocking Peptide, MTCP1 Blocking Peptide, SAP Blocking Peptide, XLP Blocking Peptide, XLPD Blocking Peptide, SH2D1A, SHD1A-2, SHD1A 2, SHD1A-2 Blocking Peptide, SHD1A 2 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- SH2D1A (SH2 Domain Containing 1A (SH2D1A))
- Hintergrund
- SH2D1A is a protein that plays a major role in the bidirectional stimulation of T and B cells. It associates with the signaling lymphocyte-activation molecule, thereby acting as an inhibitor of this transmembrane protein by blocking the recruitment of the SH2-domain-containing signal-transduction molecule SHP-2 to its docking site. This protein can also bind to other related surface molecules that are expressed on activated T, B and NK cells, thereby modifying signal transduction pathways in these cells. Mutations in SH2D1A gene cause lymphoproliferative syndrome X-linked type 1 or Duncan disease, a rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus, with symptoms including severe mononucleosis and malignant lymphoma.
- Molekulargewicht
- 14 kDa
-
Sie sind hier:
